Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial. - Weinblatt, ME; Kavanaugh, A; Burgos-Vargas, R (Arthritis Rheum, 2008)
et al.